$ALT
Altimmune Inc Stock $alt

$alt Overview Financials Valuation SEC Filings Company Website

2018 Q2 Form 10-Q Financial Statement

#000119312518164171 Filed on May 15, 2018

Income Statement

Concept	2018 Q2	2018 Q1	2017 Q1
Revenue	$2.417M	$2.691M	$299.6K
YoY Change	-20.44%	798.28%	-70.34%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.930M	$2.450M	$2.030M
YoY Change	63.69%	20.69%	70.59%
% of Gross Profit
Research & Development	$4.919M	$5.747M	$2.786M
YoY Change	-6.39%	106.27%	170.73%
% of Gross Profit
Depreciation & Amortization	$70.00K	$25.06K	$12.97K
YoY Change	40.0%	93.29%	-67.59%
% of Gross Profit
Operating Expenses	$7.853M	$8.686M	$4.817M
YoY Change	11.4%	80.32%	368.03%
Operating Profit	-$5.436M	-$5.995M	-$4.517M
YoY Change	35.51%	32.71%	260.09%
Interest Expense	$1.921K	$870.00	$60.60K
YoY Change	-98.02%	-98.56%	5671.71%
% of Operating Profit
Other Income/Expense, Net	-$5.200M	$1.829M	-$61.71K
YoY Change	5502.02%	-3064.29%
Pretax Income	-$10.64M	-$4.165M	-$4.579M
YoY Change	159.15%	-9.03%	278.41%
Income Tax	-$1.497M	-$991.6K	-$1.001M
% Of Pretax Income
Net Earnings	-$9.139M	-$3.174M	-$4.579M
YoY Change	193.82%	-30.69%	273.2%
Net Earnings / Revenue	-378.08%	-117.93%	-1528.45%
Basic Earnings Per Share
Diluted Earnings Per Share	-$9.621M	-$4.731M	-$19.91M
COMMON SHARES
Basic Shares Outstanding	25.80M shares	22.27M shares	68.82M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2018 Q2	2018 Q1	2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.200M	$4.600M	$15.80M
YoY Change	-50.0%	-70.89%	11.27%
Cash & Equivalents	$4.171M	$4.560M	$15.78M
Short-Term Investments			$0.00
Other Short-Term Assets	$1.300M	$4.900M	$500.0K
YoY Change	-7.14%	880.0%	0.0%
Inventory
Prepaid Expenses
Receivables	$2.900M	$3.800M	$1.000M
Other Receivables	$3.500M	$6.600M	$1.000M
Total Short-Term Assets	$11.87M	$19.92M	$18.29M
YoY Change	-30.18%	8.9%	13.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.476M	$1.375M	$87.94K
YoY Change	403.33%	1463.54%	-56.03%
Goodwill		$0.00	$2.348M
YoY Change		-100.0%
Intangibles	$38.35M	$39.35M
YoY Change	0.57%
Long-Term Investments
YoY Change
Other Assets	$411.3K	$225.1K
YoY Change	1748.56%
Total Long-Term Assets	$40.24M	$40.95M	$2.436M
YoY Change	-45.51%	1580.6%	-6.29%
TOTAL ASSETS
Total Short-Term Assets	$11.87M	$19.92M	$18.29M
Total Long-Term Assets	$40.24M	$40.95M	$2.436M
Total Assets	$52.10M	$60.87M	$20.73M
YoY Change	-42.65%	193.64%	10.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$245.3K	$513.2K	$839.5K
YoY Change	-78.31%	-38.87%	319.73%
Accrued Expenses	$5.306M	$4.528M	$1.400M
YoY Change	23.39%	223.44%	-30.0%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$1.300M	$0.00
YoY Change
Total Short-Term Liabilities	$7.067M	$5.155M	$2.235M
YoY Change	27.84%	130.7%	-14.05%
LONG-TERM LIABILITIES
Long-Term Debt	$600.0K	$600.0K	$0.00
YoY Change	0.0%
Other Long-Term Liabilities	$3.700M	$3.200M	$442.6K
YoY Change	1750.0%	623.02%	-11.48%
Total Long-Term Liabilities	$4.300M	$3.800M	$442.6K
YoY Change	437.5%	758.58%	-11.48%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.067M	$5.155M	$2.235M
Total Long-Term Liabilities	$4.300M	$3.800M	$442.6K
Total Liabilities	$15.78M	$14.37M	$2.677M
YoY Change	6.17%	436.83%	-13.64%
SHAREHOLDERS EQUITY
Retained Earnings	-$90.00M	-$80.86M	-$32.07M
YoY Change	131.07%	152.15%	-85.74%
Common Stock	$3.737K	$2.225K	$6.882K
YoY Change	142.35%	-67.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$35.81M	$40.54M	$29.10M
YoY Change
Total Liabilities & Shareholders Equity	$52.10M	$60.87M	$20.73M
YoY Change	-42.65%	193.64%	10.64%

Cashflow Statement

Concept	2018 Q2	2018 Q1	2017 Q1
OPERATING ACTIVITIES
Net Income	-$9.139M	-$3.174M	-$4.579M
YoY Change	193.82%	-30.69%	273.2%
Depreciation, Depletion And Amortization	$70.00K	$25.06K	$12.97K
YoY Change	40.0%	93.29%	-67.59%
Cash From Operating Activities	$350.0K	-$3.559M	-$3.340M
YoY Change	-104.48%	6.55%	145.59%
INVESTING ACTIVITIES
Capital Expenditures	-$170.0K	$652.6K	$39.58K
YoY Change	240.0%	1548.82%	26288.0%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$200.0K
YoY Change		-100.0%
Cash From Investing Activities	-$170.0K	-$667.5K	$140.0K
YoY Change	-101.25%	-576.76%
FINANCING ACTIVITIES
Cash Dividend Paid			$200.3M
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.460M	18.49K	3.050M
YoY Change	1630.0%	-99.39%	15150.0%
NET CHANGE
Cash From Operating Activities	350.0K	-3.559M	-3.340M
Cash From Investing Activities	-170.0K	-667.5K	140.0K
Cash From Financing Activities	-3.460M	18.49K	3.050M
Net Change In Cash	-3.280M	-4.210M	-150.0K
YoY Change	-158.36%	2706.38%	-88.81%
FREE CASH FLOW
Cash From Operating Activities	$350.0K	-$3.559M	-$3.340M
Capital Expenditures	-$170.0K	$652.6K	$39.58K
Free Cash Flow	$520.0K	-$4.211M	-$3.380M
YoY Change	-106.7%	24.61%	148.47%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-3961515
CY2018Q1	us-gaap	Assets Assets	60866721
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4559894
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8094068
CY2018Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2018Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	22250337	shares
CY2018Q1	us-gaap	Construction Payable Current ConstructionPayableCurrent	67620
CY2018Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2350085	shares
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q2	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	2183671
CY2018Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	25802072	shares
CY2017Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2737708
CY2017Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	661888	shares
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	29102886
CY2018Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4528125
CY2018Q1	us-gaap	Assets Current AssetsCurrent	19920760
CY2018Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	486556
CY2018Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	125357899
CY2018Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	513168
CY2018Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3754976
CY2018Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	22271635	shares
CY2018Q1	us-gaap	Common Stock Value CommonStockValue	2225
CY2018Q1	us-gaap	Deferred Compensation Cashbased Arrangements Liability Classified Noncurrent DeferredCompensationCashbasedArrangementsLiabilityClassifiedNoncurrent	286
CY2018Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	44753
CY2018Q1	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1117835
CY2018Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	5440450
CY2018Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	1852887
CY2018Q1	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	154733
CY2018Q1	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	19385
CY2018Q1	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	34278
CY2018Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	614628
CY2018Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	34278
CY2018Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	501569
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	15997
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	330000
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	15997
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	36556
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	50003
CY2018Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	990441
CY2018Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	488872
CY2018Q1	us-gaap	Goodwill Goodwill	0
CY2018Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	40319
CY2018Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	6622352
CY2018Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	39345901
CY2018Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	39847470
CY2018Q1	us-gaap	Interest Payable Current InterestPayableCurrent	536
CY2018Q1	us-gaap	Liabilities Liabilities	14371973
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	60866721
CY2018Q1	us-gaap	Liabilities Current LiabilitiesCurrent	5155133
CY2018Q1	us-gaap	Notes Payable Current NotesPayableCurrent	49702
CY2018Q1	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	3776390
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	225133
CY2018Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1449364
CY2018Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1374927
CY2018Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	3534174
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-80858377
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	138896
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	4.02
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	930852	shares
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	40540232
CY2018Q1	alt	Accrued Property And Equipment Purchases AccruedPropertyAndEquipmentPurchases	142950
CY2018Q1	alt	Accrued Research And Development AccruedResearchAndDevelopment	3215835
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2876113
CY2016Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	612112	shares
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	32207323
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3625257
CY2017Q4	us-gaap	Assets Current AssetsCurrent	23465867
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	835326
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	121655838
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	129075
CY2017Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	3806239
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4576986
CY2017Q4	us-gaap	Assets Assets	63030200
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8769465
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	12303639
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18103691	shares
CY2017Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	328384
CY2017Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	2350085	shares
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18127119	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	1810
CY2017Q4	us-gaap	Deferred Compensation Cashbased Arrangements Liability Classified Noncurrent DeferredCompensationCashbasedArrangementsLiabilityClassifiedNoncurrent	315
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	19753
CY2017Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	386489
CY2017Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	5938402
CY2017Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3400869
CY2017Q4	us-gaap	Deferred Rent Credit Current DeferredRentCreditCurrent	15914
CY2017Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	159671
CY2017Q4	us-gaap	Embedded Derivative Fair Value Of Embedded Derivative Liability EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability	27236
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	909455
CY2017Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	27236
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	486941
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	963340
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	476399
CY2017Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	6361657
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	38722270
CY2017Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	39209211
CY2017Q4	us-gaap	Interest Payable Current InterestPayableCurrent	536
CY2017Q4	us-gaap	Liabilities Liabilities	14352610
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	63030200
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3839701
CY2017Q4	us-gaap	Notes Payable Current NotesPayableCurrent	49702
CY2017Q4	us-gaap	Other Long Term Debt Noncurrent OtherLongTermDebtNoncurrent	4574507
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	238917
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	994332
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	603146
CY2017Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	3534174
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-77684839
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	138896
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1706243	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.55
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	39395823
CY2017Q4	alt	Accrued Research And Development AccruedResearchAndDevelopment	1551556
CY2017Q2	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	6883498	shares
CY2017Q2	us-gaap	Debt Instrument Convertible Number Of Equity Instruments DebtInstrumentConvertibleNumberOfEquityInstruments	316734	pure
CY2017Q2	alt	Discount Rate To Determine Present Value Of Cash Flow DiscountRateToDeterminePresentValueOfCashFlow	0.23	pure
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	pure
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y7M6D
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0216	pure
CY2017Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-579836
CY2017Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1111
CY2017Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	17295
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.9130	pure
CY2017Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	12555
CY2017Q1	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	548956
CY2017Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	345036
CY2017Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	197135
CY2017Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	38270
CY2017Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-138405
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3998945
CY2017Q1	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	49776	shares
CY2017Q1	us-gaap	Decrease In Restricted Cash DecreaseInRestrictedCash	200000
CY2017Q1	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	566793
CY2017Q1	us-gaap	Depreciation Depreciation	12966
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.68
CY2017Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7399
CY2017Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2030516
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4578781
CY2017Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	20062
CY2017Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	203008
CY2017Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-129664
CY2017Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-733736
CY2017Q1	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	3362
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1566604
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-50553
CY2017Q1	us-gaap	Interest Expense InterestExpense	60603
CY2017Q1	us-gaap	Interest Paid InterestPaid	7181
CY2017Q1	us-gaap	License And Services Revenue LicenseAndServicesRevenue	4938
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	143123
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3343177
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4697137
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	4816638
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	3054250
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-4578781
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4517067
CY2017Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-61714
CY2017Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	579836
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	39582
CY2017Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	118356
CY2017Q1	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	3018780
CY2017Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	450
CY2017Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	35020
CY2017Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	147967
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2786122
CY2017Q1	us-gaap	Revenue From Grants RevenueFromGrants	294633
CY2017Q1	us-gaap	Sales Revenue Net SalesRevenueNet	299571
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	345036
CY2017Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	450
CY2017Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6917708	shares
CY2017Q1	alt	Noncash Or Part Noncash Acquisition Accrued Expense Capitalized As Convertible Notes NoncashOrPartNoncashAcquisitionAccruedExpenseCapitalizedAsConvertibleNotes	842604
CY2018Q1	us-gaap	Adjustment For Amortization AdjustmentForAmortization	14628
CY2018Q1	dei	Amendment Flag AmendmentFlag	false
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation	18351
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	356709
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	363788
CY2018Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	142950
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4209571
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2558067
CY2018Q1	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1		shares
CY2018Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018Q1	us-gaap	Depreciation Depreciation	25062
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.25
CY2018Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.169	pure
CY2018Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2018Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018Q1	dei	Document Type DocumentType	10-Q
CY2018Q1	dei	Document Period End Date DocumentPeriodEndDate	2018-03-31
CY2018Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1895
CY2018Q1	dei	Entity Registrant Name EntityRegistrantName	ALTIMMUNE, INC.
CY2018Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001326190
CY2018Q1	dei	Entity Filer Category EntityFilerCategory	Smaller Reporting Company
CY2018Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-7042
CY2018Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	490676
CY2018Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	490676
CY2018Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2447894
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4165176
CY2018Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-615471
CY2018Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	497952
CY2018Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	20062
CY2018Q1	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	694200
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-51263
CY2018Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	716934
CY2018Q1	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	-49845
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-991638
CY2018Q1	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	271356
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	376347
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-246403
CY2018Q1	us-gaap	Interest Expense InterestExpense	870
CY2018Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	31590
CY2018Q1	us-gaap	Interest Paid InterestPaid	870
CY2018Q1	us-gaap	License And Services Revenue LicenseAndServicesRevenue	4938
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-667463
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3558701
CY2018Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5064859
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	8685541
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	18488
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-3173538
CY2018Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-5994561
CY2018Q1	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	12273
CY2018Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1829385
CY2018Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	615471
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	257725
CY2018Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	14828
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	652635
CY2018Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	1891321
CY2018Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	18488
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5746971
CY2018Q1	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-7049
CY2018Q1	us-gaap	Revenue From Grants RevenueFromGrants	2686042
CY2018Q1	us-gaap	Sales Revenue Net SalesRevenueNet	2690980
CY2018Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-7042
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	356709
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y4M6D
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y4M13D
CY2018Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.19
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	pure
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0251	pure
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y0M18D
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.8670	pure
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y7M24D
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost	91957
CY2018Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	775391	shares
CY2018Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	5218570
CY2018Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	18488
CY2018Q1	dei	Trading Symbol TradingSymbol	ALT
CY2018Q1	us-gaap	Unrealized Gain Loss On Securities UnrealizedGainLossOnSecurities	1547982
CY2018Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	20145270	shares
CY2018Q1	alt	Exchange Of Stock ExchangeOfStock	1-for-1 basis
CY2018Q1	alt	Adjustments To Additional Paid In Capital Accretion Of Convertible Preferred Stock AdjustmentsToAdditionalPaidInCapitalAccretionOfConvertiblePreferredStock	1891321
CY2018Q1	alt	Noncash Or Part Noncash Acquisition Lease Incentive Billed But Not Yet Received NoncashOrPartNoncashAcquisitionLeaseIncentiveBilledButNotYetReceived	684972

Files In Submission

Name	View Source	Status
0001193125-18-164171-index-headers.html	Edgar Link	pending
0001193125-18-164171-index.html	Edgar Link	pending
0001193125-18-164171.txt	Edgar Link	pending
0001193125-18-164171-xbrl.zip	Edgar Link	pending
alt-20180331.xml	Edgar Link	completed
alt-20180331.xsd	Edgar Link	pending
alt-20180331_cal.xml	Edgar Link	unprocessable
alt-20180331_def.xml	Edgar Link	unprocessable
alt-20180331_lab.xml	Edgar Link	unprocessable
alt-20180331_pre.xml	Edgar Link	unprocessable
d575889d10q.htm	Edgar Link	pending
d575889dex311.htm	Edgar Link	pending
d575889dex312.htm	Edgar Link	pending
d575889dex321.htm	Edgar Link	pending
d575889dex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALT
Altimmune Inc Stock $alt

2018 Q2 Form 10-Q Financial Statement

#000119312518164171 Filed on May 15, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALT Altimmune Inc Stock $alt

2018 Q2 Form 10-Q Financial Statement

#000119312518164171 Filed on May 15, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALT
Altimmune Inc Stock $alt